From: Clinical evaluation of two AI models for automated breast cancer plan generation
PTV | Lungs | Heart | ||||
---|---|---|---|---|---|---|
Average dose [Gy] | Difference w.r.t. prescribed dose [%] | D2% [Gy] | MLD [Gy] | V5Gy [cm3] | MHD [Gy] | |
Clinical | 40.07 ± 0.40 | + 0.1 | 41.69 ± 0.57 | 1.92 ± 0.62 | 325 ± 85 | 1.17 ± 0.77 |
cARF | 40.37 ± 0.35* | + 0.8 | 42.01 ± 0.56* | 1.98 ± 0.64* | 333 ± 87* | 1.23 ± 0.76* |
U-net | 40.53 ± 0.36* | + 1.2 | 42.02 ± 0.56* | 1.96 ± 0.64 | 331 ± 86 | 1.24 ± 0.87* |